Clinical impact of occult HBV infections (Q36388359)

13 August 2017

1 reference

title

Clinical impact of occult HBV infections (English)

1 reference

13 August 2017

Chemin I

1 reference

13 August 2017

Trépo C

series ordinal

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Journal of Clinical Virology

13 August 2017

published in

1 reference

13 August 2017

volume

34 Suppl 1

1 reference

13 August 2017

page(s)

S15-21

1 reference

Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis: genetic variability and its potential role in disease pathogenicity

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Vaccine-induced escape mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

"Occult" hepatitis B virus as source of infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Occult hepatitis B virus infection: a hidden menace?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

The impact of previous HBV infection on the course of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatocellular Carcinoma and Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Clinical relevance of hepatitis B viral mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Occult hepatitis B virus infection in a North American adult hemodialysis patient population

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatitis B virus multiplication in the absence of usual serological markers. A study of 146 chronic alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Presence of hepatitis B virus DNA in serum of surface-antigen-seronegative immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Persistence of Hepatitis B and Hepatitis C Viral Genomes in Primary Liver Cancers from HBsAg-Negative Patients: A Study of a Low-endemic Area

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Occult hepatitis B virus infection and liver disease: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Molecular mechanism of hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Detection of hepatitis B virus DNA in tissues of hepatocellular carcinomas related to hepatitis C virus which are negative for hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Studies of donors who transmit posttransfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Transmission of hepatitis B from hepatitis-B-seronegative subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: Probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatitis B virus and apparent fulminant non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Factors associated with viremia and elevated transaminase levels in asymptomatic hepatitis D virus-infected risk groups

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2805%2980005-8

7 January 2021

10.1016/S1386-6532(05)80005-8

Identifiers

DOI

1 reference

13 August 2017

1 reference